Imaging of the pulmonary vasculature is crucial for our understanding of the short- and long-term consequences of COVID-19 Prof. William Li, president and medical director of the Angiogenesis Foundation, explains during an interview in Fluidda Magazine #2.
Angiogenesis and vascular imaging form a very pressing issue to emerge from this pandemic. The need for novel parameters, such as the FRI parameter BVX, is essential to tackle long COVID, and can be a novel turnkey for drug developers.
A study under the co-authorship of Li examined the associated morphologic and molecular changes in the peripheral lungs of patients who died from COVID-19. By affecting the vascular endothelium inside the lungs, the virus changed gene expression,
altered cell shape, altered vascular function at a microcirculatory level, and caused reactive angiogenesis very similar to wound healing.
To read more, you can download the full article HERE.
COVID, COVID-19, FRI